People

Arikayce inhaled liposomal amikacin developer Insmed has announced that former AstraZeneca CEO David R. Brennan will join the company's board of directors. Insmed Chairman of the Board Donald J. Hayden commented, "We are delighted to welcome David to the Insmed Board. David's deep and diverse set of global operating experiences will be invaluable as we build … [Read more...] about Insmed adds former AstraZeneca CEO to its board

Discovery Laboratories has hired former AstraZeneca Senior Medical Director Steve Simonson as VP, Clinical Development and former PARI VP and Director of Product Technology Lawrence Weinstein as VP, Medical Device Development, the company said. The new hires, both of whom have extensive OINDP experience, will oversee development of the Aerosurf aerosolized KL4 … [Read more...] about Discovery Labs announces two hires to oversee Aerosurf development

Alexza Pharmaceuticals has hired Winston R. Brown, Jr. as VP, Quality, the company has announced. Brown was most recently Global Head, Quality R&D - Pharmaceuticals, Biologics, and Vision Care Devices at Alcon Research. The company has made several hires recently as it is in the process of commercializing its Adasuve inhaled loxapine for the treatment of … [Read more...] about Alexza hires Winston R. Brown, Jr. as VP, Quality

In anticipation of the potential commercialization of its Arikayce inhaled liposomal amikacin, Insmed has announced a number of management changes designed to "better align the organization with the company's growth opportunities." Those changes are: Renu Gupta, currently Executive VP of Development and Chief Medical Officer, will become Special Advisor to the … [Read more...] about Insmed announces management changes

The FDA has announced a funding opportunity for a research project titled "Development of Clinically Relevant In Vitro Performance Test for Generic OIDPs: Physiologically Relevant Models for Aerodynamic Particle Size Distribution Analysis." Two grants of $500,000 each are available. The stated goal of the project is "to investigate if realistic physical … [Read more...] about FDA announces funding opportunity for research on realistic mouth-throat models

3M Drug Delivery Systems has announced that Cindy R. Kent has succeeded James Ingebrand as President and General Manager, effective February 2014. Ingebrand will now head 3M's dental division. Kent joined 3M in October 2013 as VP of Strategy, Business Development and US Medical Key Accounts for 3M Healthcare. She holds degrees in industrial engineering, management, … [Read more...] about 3M Drug Delivery Systems names Cindy Kent President and General Manager